2024
Preoperative Evaluation of Vitreoretinal Surgery Patients
Chancellor J, Adelman R, Siddiqui M. Preoperative Evaluation of Vitreoretinal Surgery Patients. 2024, 17-25. DOI: 10.1007/978-3-031-47827-7_2.Peer-Reviewed Original ResearchPreoperative evaluationAccurate preoperative evaluationInfluence surgical outcomesEffective preoperative evaluationLens statusVitreous statusFellow eyesIntraocular pressureOptimal patient satisfactionCorneal healthVisual acuityRetinal examinationSurgical successVitreoretinal surgerySurgical outcomesPostoperative outcomesVisual improvementPreoperative assessmentSurgical techniqueSurgical planningPatient characteristicsPotential complicationsPostoperative expectationsPatient satisfactionPatients
2021
HEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS AFTER INTRACAMERAL VANCOMYCIN USE IN CATARACT SURGERY AFTER INTRAVENOUS EXPOSURE
Alasil T, Wong JJY, Adelman RA, Tom D, Coady PA. HEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS AFTER INTRACAMERAL VANCOMYCIN USE IN CATARACT SURGERY AFTER INTRAVENOUS EXPOSURE. Retinal Cases & Brief Reports 2021, Publish Ahead of Print: &na;. PMID: 29474222, DOI: 10.1097/icb.0000000000000725.Peer-Reviewed Original ResearchConceptsHemorrhagic occlusive retinal vasculitisOcclusive retinal vasculitisCataract surgeryLeft eyeIntracameral vancomycinRetinal vasculitisSystemic vancomycinHypersensitivity reactionsPan-retinal photocoagulationPeripheral retinal hemorrhagesFavorable visual outcomeUncomplicated cataract surgeryOral prednisoneFundus examinationRetinal ischemiaVisual outcomeFellow eyesInfection prophylaxisRetinal hemorrhagesBlurry visionVisual acuityAnterior chamberIntraocular lensIschemic areaVasculitis cases
2020
VISUAL OUTCOME OF EARLY VITRECTOMY AND INTRAVITREAL ANTIBIOTICS IN ACUTE POSTSURGICAL AND POSTINTRAVITREAL INJECTION ENDOPHTHALMITIS: European Vitreo-Retinal Society Endophthalmitis Study Report Two.
Soliman MK, Gini G, Kuhn F, Parolini B, Ozdek S, Adelman RA, Sallam AB. VISUAL OUTCOME OF EARLY VITRECTOMY AND INTRAVITREAL ANTIBIOTICS IN ACUTE POSTSURGICAL AND POSTINTRAVITREAL INJECTION ENDOPHTHALMITIS: European Vitreo-Retinal Society Endophthalmitis Study Report Two. Retina 2020, 41: 423-430. PMID: 32467482, DOI: 10.1097/iae.0000000000002856.Peer-Reviewed Original ResearchConceptsIntravitreal antibioticsPPV groupEarly PPVVisual outcomeRetinal detachmentPostintravitreal injection endophthalmitisRetrospective multicenter cohortFinal visual acuityWeeks of presentationDays of presentationMethod of treatmentEarly vitrectomyMulticenter cohortIntravitreal injectionPlana vitrectomyRetina specialistsVisual acuityMean ageIntraocular proceduresEndophthalmitisSimilar outcomesLight perceptionEyesVitrectomyOutcomes
2017
Vitrectomy in the management of diabetic macular edema in treatment-naïve patients
Michalewska Z, Stewart MW, Landers MB, Bednarski M, Adelman RA, Nawrocki J. Vitrectomy in the management of diabetic macular edema in treatment-naïve patients. Canadian Journal Of Ophthalmology 2017, 53: 402-407. PMID: 30119796, DOI: 10.1016/j.jcjo.2017.10.011.Peer-Reviewed Original ResearchConceptsTreatment-naïve diabetic macular edemaDiabetic macular edemaCentral retinal thicknessPars plana vitrectomyMacular edemaVisual acuityPlana vitrectomyMean central retinal thicknessDuration of diabetesProspective randomized trialsTreatment-naïve patientsInitial visual acuityVisual acuity changesPrimary outcome measureEfficacy of vitrectomyElectronic medical recordsEarly vitrectomyIntravitreal bevacizumabFinal BCVAMean BCVAPrimary endpointRetinal thicknessConsecutive patientsRandomized trialsRetrospective studyAge‐related macular degeneration: using morphological predictors to modify current treatment protocols
Ashraf M, Souka A, Adelman RA. Age‐related macular degeneration: using morphological predictors to modify current treatment protocols. Acta Ophthalmologica 2017, 96: 120-133. PMID: 29130626, DOI: 10.1111/aos.13565.Peer-Reviewed Original ResearchConceptsAge-related macular degenerationPigment epithelial detachmentChoroidal neovascular membranePosterior vitreous detachmentNeovascular age-related macular degenerationRetinal angiomatous proliferationSubretinal fluidIntraretinal cystsVitreomacular adhesionVisual outcomeVisual acuityPrognostic indicatorMacular degenerationAnti-vascular endothelial growth factorLarger choroidal neovascular membranesWet age-related macular degenerationOlder ageCNV sizeFinal visual outcomeGood visual outcomeAnti-VEGF therapyPoor prognostic indicatorCurrent treatment protocolsEndothelial growth factorInjection frequencyCharacteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom
Alasil T, Munoz N, Keane PA, Tufail A, Coady PA, Novais E, de Carlo TE, Baumal CR, Waheed NK, Duker JS, Adelman RA. Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom. International Journal Of Retina And Vitreous 2017, 3: 9. PMID: 28428893, PMCID: PMC5392942, DOI: 10.1186/s40942-017-0060-4.Peer-Reviewed Original ResearchPolypoidal choroidal vasculopathyFinal visual acuityWorse visual outcomeVisual acuityBilateral diseaseVisual outcomeTertiary centerFemale predominanceChoroidal vasculopathyDiagnosis of PCVInitial visual acuityRacial variationMulticenter retrospective studyLength of followDifferent treatment modalitiesSignificant decreaseIndocyanine green angiography imagesLens statusPCV patientsVision gainInitial presentationRetrospective studyWorse visionPolypoidal lesionsTreatment modalitiesNovel therapeutics for Stargardt disease
Lu LJ, Liu J, Adelman RA. Novel therapeutics for Stargardt disease. Graefe's Archive For Clinical And Experimental Ophthalmology 2017, 255: 1057-1062. PMID: 28285324, DOI: 10.1007/s00417-017-3619-8.Peer-Reviewed Original ResearchConceptsStargardt diseaseVision lossABCA4 geneStem cell transplantationSevere vision lossPromising treatment candidateNovel therapeutic strategiesRetinal pigment epitheliumStem cell therapyVisual acuityStandard treatmentMacular degenerationTreatment candidatesHESC-RPE cellsStargardt patientsTherapeutic strategiesPharmacological agentsPigment epitheliumMacular dystrophyNovel therapeuticsPatientsDiseaseVisual cyclePrevalent formSecond decadeAsymmetric Deep Stromal Keratopathy in a Patient With Multiple Myeloma
Tainsh LT, Coady PA, Sinard JH, Neparidze N, Meskin SW, Adelman RA, Chow J. Asymmetric Deep Stromal Keratopathy in a Patient With Multiple Myeloma. Cornea 2017, 36: 372-374. PMID: 28079685, DOI: 10.1097/ico.0000000000001139.Peer-Reviewed Original ResearchConceptsMultiple myelomaVisual acuityRight eye 2 yearsDeep stromal opacitiesEye 2 yearsPatient's visual acuityDiagnosis of IgGParaproteinemic keratopathyInitial presentationStromal lesionsStromal opacityCase reportHematologic workupMonoclonal gammopathyAsymmetric presentationUnusual casePosterior stromaMyelomaKeratopathyPatientsDiagnosisPresentationLiterature reviewKeratoplastyAcuity
2016
Pneumatic retinopexy for displaced macular laceration from intraocular foreign body
Coady PA, Chaudhry N, Adelman RA. Pneumatic retinopexy for displaced macular laceration from intraocular foreign body. American Journal Of Ophthalmology Case Reports 2016, 4: 18-20. PMID: 29503916, PMCID: PMC5757453, DOI: 10.1016/j.ajoc.2016.07.002.Peer-Reviewed Original ResearchIntraocular foreign bodyPars plana vitrectomyPneumatic retinopexyForeign bodyPlana vitrectomyRemoval of IOFBMetallic intraocular foreign bodyPrompt pars plana vitrectomyRetinal pigment epithelial atrophyPigment epithelial atrophyYear old manOptical coherence tomographyIntravitreal antibioticsEpithelial atrophyLeft globeVisual acuityTraumatic lacerationsFoveal tissueOlder menLacerationRetinopexyCoherence tomographyGood visual resultsSubsequent healingPosterior pointPredicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature
Ashraf M, Souka A, Adelman R. Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature. British Journal Of Ophthalmology 2016, 100: 1596. PMID: 27231313, DOI: 10.1136/bjophthalmol-2016-308388.Peer-Reviewed Original ResearchConceptsDiabetic macular edemaOptical coherence tomographyMacular edemaAnti-vascular endothelial growth factor therapyIntravitreal anti-vascular endothelial growth factorAnti-vascular endothelial growth factorEndothelial growth factor therapyFluorescein angiography findingsAnti-VEGF therapyAnti-VEGF agentsGrowth factor therapyCourse of treatmentCommon prognostic indicatorsEndothelial growth factorFactor therapyMost patientsVisual outcomeAngiography findingsChoroidal thicknessLarge RCTsTreatment regimenOCT parametersVisual acuityPrognostic indicatorDifferent RCTs
2015
TEMPORAL INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE VERSUS CLASSIC INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE
Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Adelman RA, Nawrocki J. TEMPORAL INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE VERSUS CLASSIC INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE. Retina 2015, 35: 1844-1850. PMID: 25946691, DOI: 10.1097/iae.0000000000000555.Peer-Reviewed Original ResearchConceptsILM flap techniqueFlap techniqueMacular holeGroup BGroup AOptic nerve fiber layer appearanceProspective comparative interventional studyFinal visual acuityINTERNAL LIMITING MEMBRANE FLAPIdiopathic macular holeNumber of patientsComparative interventional studyStage IV macular holesInternal Limiting MembranePostoperative examinationConsecutive eyesVisual acuityInterventional studyTemporal sideGroup A.ILM flapTreatment groupsMembrane flapSatisfactory outcomeLimiting MembraneVisual recovery following open globe injury with initial no light perception
Han YS, Kavoussi SC, Adelman RA. Visual recovery following open globe injury with initial no light perception. Clinical Ophthalmology 2015, Volume 9: 1443-1448. PMID: 26316683, PMCID: PMC4540122, DOI: 10.2147/opth.s87852.Peer-Reviewed Original ResearchOpen globe injuriesVisual recoveryGlobe injuriesExact testLight perceptionOcular Trauma ScoreOcular examination findingsCharacteristics of injuriesFisher's exact testUnpaired t-testSecondary enucleationVisual outcomeConsecutive patientsExamination findingsSurgical interventionVisual acuityMean agePrognostic indicatorSingle institutionOphthalmic historyTrauma ScoreInclusion criteriaPatientsSelect casesWound sizeCharacteristics and outcomes of fall-related open-globe injuries in pseudophakic patients
Kavoussi SC, Slade MD, Meskin SW, Adelman RA. Characteristics and outcomes of fall-related open-globe injuries in pseudophakic patients. Clinical Ophthalmology 2015, Volume 9: 403-408. PMID: 25784783, PMCID: PMC4356447, DOI: 10.2147/opth.s73757.Peer-Reviewed Original ResearchOcular Trauma ScoreOpen globe injuriesPseudophakic patientsSubconjunctival hemorrhageTotal hyphemaFinal BCVAAnatomic outcomesSurgical interventionExact testWound sizeLow ocular trauma scoreConsecutive pseudophakic patientsMultiple surgical interventionsCircumstances of injuryLarger wound sizeFisher's exact testCase series designUnpaired t-testInitial BCVANineteen patientsPosterior injuryRetinal detachmentExamination findingsVisual acuityMean ageStrategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study
Adelman RA, Parnes AJ, Bopp S, Othman I, Ducournau D. Strategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study. BioMed Research International 2015, 2015: 870987. PMID: 25705695, PMCID: PMC4325227, DOI: 10.1155/2015/870987.Peer-Reviewed Original ResearchConceptsRetinal vein occlusionCentral retinal vein occlusionBranch retinal vein occlusionVein occlusionMacular edemaVisual acuityIntravitreal antivascular endothelial growth factor injectionsAntivascular endothelial growth factor injectionsCases of RVOEndothelial growth factor injectionsGrowth factor injectionsChoice of treatmentMulticenter collaborative studyEdema studyFactor injectionsNonsurgical treatmentNumber of treatmentsVEGF injectionPlana vitrectomyRVO casesILM peelingRetina specialistsVisual gainDiagnostic findingsVisual improvementStrategy for the Management of Diabetic Macular Edema: The European Vitreo‐Retinal Society Macular Edema Study
Adelman R, Parnes A, Michalewska Z, Parolini B, Boscher C, Ducournau D. Strategy for the Management of Diabetic Macular Edema: The European Vitreo‐Retinal Society Macular Edema Study. BioMed Research International 2015, 2015: 352487. PMID: 25695062, PMCID: PMC4324105, DOI: 10.1155/2015/352487.Peer-Reviewed Original ResearchConceptsDiabetic macular edemaMacular edemaVisual acuityVisual improvementBetter visual improvementMulticenter clinical studyPars plana vitrectomySignificant visual improvementEdema studyTriamcinolone monotherapyVEGF therapyVEGF injectionVision gainClinical findingsGrid laserPlana vitrectomyRetina specialistsClinical studiesDifferent therapiesClinical informationEdemaAcuityTherapyMean numberTreatment
2014
Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients
Hall LB, Zebardast N, Huang JJ, Adelman RA. Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients. Journal Of Ocular Pharmacology And Therapeutics 2014, 30: 346-352. PMID: 24552305, DOI: 10.1089/jop.2013.0188.Peer-Reviewed Original ResearchMeSH KeywordsAged, 80 and overAntibodies, Monoclonal, HumanizedBevacizumabFemaleHumansIntravitreal InjectionsMacular DegenerationMaleRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsRetinaRetrospective StudiesTomography, Optical CoherenceTreatment OutcomeVascular Endothelial Growth Factor AVisual AcuityConceptsAge-related macular degenerationCentral macular thicknessAflibercept injectionsInitial visitMacular degenerationAnti-vascular endothelial growth factor treatmentNeovascular age-related macular degenerationEndothelial growth factor treatmentCentral macular edemaIntraocular pressure increaseSubset of patientsMain outcome measuresOptical coherence tomographyGrowth factor treatmentMacular thicknessNeovascular AgeOcular hypertensionSubmacular fluidVisual outcomeMacular edemaRetrospective studyVisual acuityOutcome measuresStudy populationPatients
2012
Intravitreal Ranibizumab for Treatment of Choroidal Neovascularization Secondary to Angioid Streaks in Pseudoxanthoma Elasticum: Five-year Follow-up
Zebardast N, Adelman RA. Intravitreal Ranibizumab for Treatment of Choroidal Neovascularization Secondary to Angioid Streaks in Pseudoxanthoma Elasticum: Five-year Follow-up. Seminars In Ophthalmology 2012, 27: 61-64. PMID: 22784267, DOI: 10.3109/08820538.2012.680644.Peer-Reviewed Original ResearchConceptsChoroidal neovascularizationOptical coherence tomographyPseudoxanthoma elasticumFluorescein angiographyNeovascular activityTreatment of CNVIntravitreal ranibizumab injectionsFive yearsMacular choroidal neovascularizationLong-term effectivenessOCT evidenceIntravitreal ranibizumabRanibizumab injectionsRanibizumab therapyAffected eyeIntraretinal fluidVisual acuityFluorescein leakageAngioid streaksScar formationInitial injectionCoherence tomographyRanibizumabInjectionNeovascularizationIs Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy?
Prescott CR, Sklar CA, Lesser RL, Adelman RA. Is Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy? Journal Of Neuro-Ophthalmology 2012, 32: 51-53. PMID: 22269947, DOI: 10.1097/wno.0b013e318240596e.Peer-Reviewed Original ResearchConceptsNonarteritic anterior ischemic optic neuropathyAnterior ischemic optic neuropathyIschemic optic neuropathyVisual acuityIntravitreal bevacizumabOptic neuropathyTreatment optionsIntravitreal bevacizumab injectionEffective treatment optionVisual field defectsBevacizumab injectionFellow eyesClinical outcomesRetrospective studyTreatment modalitiesNatural courseField defectsPatientsDecreased acuitySmall seriesAcuityBevacizumabProfound lossVisual fieldNeuropathy
2011
The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab
Lee ST, Adelman RA. The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab. Journal Of Ocular Pharmacology And Therapeutics 2011, 27: 611-614. PMID: 21810026, DOI: 10.1089/jop.2011.0045.Peer-Reviewed Original ResearchConceptsRecurrent central serous chorioretinopathyMean central macular thicknessCentral macular thicknessCentral serous chorioretinopathyPreinjection visual acuityVisual acuityOptical coherence tomographyIntravitreal bevacizumabSerous chorioretinopathyTreatment optionsLow-risk treatment optionYale Eye CenterIntravitreal bevacizumab injectionRetrospective case seriesEffective treatment optionLong-term efficacySub-retinal fluidNumber of injectionsFluorescein angiography imagingBevacizumab injectionRecurrent diseaseMacular thicknessMonth 3Month 6Case series
2010
Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes
Michalewska Z, Michalewski J, Adelman RA, Nawrocki J. Inverted Internal Limiting Membrane Flap Technique for Large Macular Holes. Ophthalmology 2010, 117: 2018-2025. PMID: 20541263, DOI: 10.1016/j.ophtha.2010.02.011.Peer-Reviewed Original ResearchConceptsLarge macular holesILM flap techniqueMacular hole closureMembrane flap techniqueMacular holeGroup 2Group 1Visual acuityFlap techniqueOptical coherence tomographySpectral optical coherence tomographyAnatomic outcomesHole closureStandard macular hole surgeryInternal Limiting Membrane Flap TechniqueCoherence tomographyVisual acuity 12 monthsPars plana vitrectomyMacular hole surgeryFluid-air exchangeLimited visual acuityRetinal pigment epitheliumSurgical failureFoveal anatomyPlana vitrectomy